Switzerland Blood Plasma & Plasma Derived Medicinal Products Market to 2032

Overview

The Switzerland Blood Plasma & Plasma Derived Medicinal Products Market is expected to reach a 653.25 USD Million by 2032 and is projected to grow at a CAGR of 6.61% from 2025 to 2032.

Revenue, 2024 (USD Million)
393.06
Forecast, 2032 (USD Million)
653.25
CAGR, 2024 - 2032
6.61%
Report Coverage
Switzerland

Switzerland Blood Plasma & Plasma Derived Medicinal Products Market 2018-2032 USD Million

Switzerland Blood Plasma & Plasma Derived Medicinal Products Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 393.06 USD Million
  • Projected Market Size (2032): 653.25 USD Million
  • CAGR (2025-2032): 6.61%

Key Findings of Switzerland Blood Plasma & Plasma Derived Medicinal Products Market

  • The Switzerland Blood Plasma & Plasma Derived Medicinal Products Market was valued at 393.06 USD Million in 2024.
  • The Switzerland Blood Plasma & Plasma Derived Medicinal Products Market is likely to grow at a CAGR of 6.61% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Modern in Mode Segment accounted for the largest share of the market with a revenue of 290.89 USD Million
  • The fastest growing segment Immunology in Application Segment grew Fastest with a CAGR of 7.16% during the forecast period from 2024 to 2032.

Switzerland Blood Plasma & Plasma Derived Medicinal Products Market Scope

Switzerland Blood Plasma & Plasma Derived Medicinal Products Market Segmentation & Scope
Product
  • Monoclonal Antibodies (Derived from Plasma Cells)
  • Other Plasma Derived Proteins
  • Protease Inhibitors (For Genetic Deficiencies)
  • Albumin (Plasma Volume Expander)
  • Coagulation Factors (For Bleeding Disorders)
  • Immunoglobulins
Distribution Channel
  • Others
  • Third Party Distributors
  • Direct Tenders
End User
  • Academic Institutes
  • Others
  • Research Labs
  • Hospitals & Clinics
Mode
  • Traditional Plasma Fractionation
  • Modern
Processing Technology
  • Microfiltration
  • Ultrafiltration
  • Cryoprecipitation
  • Affinity Chromatography
  • Ion Exchange Chromatography
Application
  • Rheumatology
  • Haemato-Oncology
  • Pulmonology
  • Other Applications
  • Neurology
  • Critical Care
  • Hematology
  • Immunology

Switzerland Blood Plasma & Plasma Derived Medicinal Products Market Data Coverage Insights

Study Period 2024-2032
Base Year 2024
Unit Revenue in USD Million
Market Value in 2024 393.06 USD Million
Market Value in 2032 653.25 USD Million
CAGR (2025-2032) 6.61%
Historic Data 2016-2023
Market Segments Covered Product,Distribution Channel,End User,Mode,Processing Technology,Application

Regional Insights:

  • Leading Market (2024-2032): Switzerland, leading in terms of revenue 393.06 USD Million in 2024
    • Key Country: Switzerland, leading in terms of revenue with value of 393.06 USD Million in 2024.

Segments and Scope

  • Switzerland Blood Plasma & Plasma Derived Medicinal Products Market to 2032, By Product
    • Immunoglobulins is the largest segment in Switzerland Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a revenue of 165.79 USD Million in the year 2024.
    • Coagulation Factors (For Bleeding Disorders) is the Fastest growing segment in Switzerland Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a Growth rate of 6.61 % in forecast period 2025-2032.
  • Switzerland Blood Plasma & Plasma Derived Medicinal Products Market to 2032, By Distribution Channel
    • Direct Tenders is the largest segment in Switzerland Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a revenue of 200.72 USD Million in the year 2024.
    • Direct Tenders is the Fastest growing segment in Switzerland Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a Growth rate of 7.01 % in forecast period 2025-2032.
  • Switzerland Blood Plasma & Plasma Derived Medicinal Products Market to 2032, By End User
    • Hospitals & Clinics is the largest segment in Switzerland Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a revenue of 265.04 USD Million in the year 2024.
    • Hospitals & Clinics is the Fastest growing segment in Switzerland Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a Growth rate of 6.83 % in forecast period 2025-2032.
  • Switzerland Blood Plasma & Plasma Derived Medicinal Products Market to 2032, By Mode
    • Modern is the largest segment in Switzerland Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a revenue of 290.89 USD Million in the year 2024.
    • Modern is the Fastest growing segment in Switzerland Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a Growth rate of 6.73 % in forecast period 2025-2032.
  • Switzerland Blood Plasma & Plasma Derived Medicinal Products Market to 2032, By Processing Technology
    • Ion Exchange Chromatography is the largest segment in Switzerland Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a revenue of 120.69 USD Million in the year 2024.
    • Affinity Chromatography is the Fastest growing segment in Switzerland Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a Growth rate of 6.71 % in forecast period 2025-2032.
  • Switzerland Blood Plasma & Plasma Derived Medicinal Products Market to 2032, By Application
    • Immunology is the largest segment in Switzerland Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a revenue of 125.44 USD Million in the year 2024.
    • Immunology is the Fastest growing segment in Switzerland Blood Plasma & Plasma Derived Medicinal Products Market to 2032 with a Growth rate of 7.16 % in forecast period 2025-2032.

Switzerland Blood Plasma & Plasma Derived Medicinal Products Market Company Share Analysis

 
Company Name Company Share Analysis
Octapharma AG
Kedrion S.p.A
Takeda Pharmaceutical Company Limited
Grifols, S.A.
CSL
Switzerland Blood Plasma & Plasma Derived Medicinal Products Market Company Share Analysis

Switzerland Blood Plasma & Plasma Derived Medicinal Products Market Geographical Sales Distribution, 2018-2032 USD Million

Switzerland Blood Plasma & Plasma Derived Medicinal Products Market Geographical Sales Distribution, 2018-2032 USD Million

Switzerland Blood Plasma & Plasma Derived Medicinal Products Market Company Profiling

Switzerland Blood Plasma & Plasma Derived Medicinal Products Market Company Profiling
Frequently Asked Questions
The Switzerland Blood Plasma & Plasma Derived Medicinal Products Market is segmented based on Segmentation Product,Distribution Channel,End User,Mode,Processing Technology,Application.
Switzerland Blood Plasma & Plasma Derived Medicinal Products Market was valued at USD 393.06(Revenue in USD Million) in 2024.
Switzerland Blood Plasma & Plasma Derived Medicinal Products Market is projected to grow at a CAGR of 6.61% during the forecast period of 2024 to 2032.
The Modern segment is expected to dominate the Switzerland Blood Plasma & Plasma Derived Medicinal Products Market, holding a largest market share of 290.89 USD Million in 2024

Coming Soon....

Switzerland Blood Plasma & Plasma Derived Medicinal Products Market Scope

Switzerland Blood Plasma & Plasma Derived Medicinal Products Market Segmentation & Scope
Product
  • Monoclonal Antibodies (Derived from Plasma Cells)
  • Other Plasma Derived Proteins
  • Protease Inhibitors (For Genetic Deficiencies)
  • Albumin (Plasma Volume Expander)
  • Coagulation Factors (For Bleeding Disorders)
  • Immunoglobulins
Distribution Channel
  • Others
  • Third Party Distributors
  • Direct Tenders
End User
  • Academic Institutes
  • Others
  • Research Labs
  • Hospitals & Clinics
Mode
  • Traditional Plasma Fractionation
  • Modern
Processing Technology
  • Microfiltration
  • Ultrafiltration
  • Cryoprecipitation
  • Affinity Chromatography
  • Ion Exchange Chromatography
Application
  • Rheumatology
  • Haemato-Oncology
  • Pulmonology
  • Other Applications
  • Neurology
  • Critical Care
  • Hematology
  • Immunology
Frequently Asked Questions
The Switzerland Blood Plasma & Plasma Derived Medicinal Products Market is segmented based on Segmentation Product,Distribution Channel,End User,Mode,Processing Technology,Application.
Switzerland Blood Plasma & Plasma Derived Medicinal Products Market was valued at USD 393.06(Revenue in USD Million) in 2024.
Switzerland Blood Plasma & Plasma Derived Medicinal Products Market is projected to grow at a CAGR of 6.61% during the forecast period of 2024 to 2032.
The estimated market value of the Switzerland Blood Plasma & Plasma Derived Medicinal Products Market for final year is USD 653.25 (USD Million).

Switzerland Blood Plasma & Plasma Derived Medicinal Products Market Company Profiling

Switzerland Blood Plasma & Plasma Derived Medicinal Products Market Company Profiling
Frequently Asked Questions
The Switzerland Blood Plasma & Plasma Derived Medicinal Products Market is segmented based on Segmentation Product,Distribution Channel,End User,Mode,Processing Technology,Application.
Switzerland Blood Plasma & Plasma Derived Medicinal Products Market was valued at USD 393.06(Revenue in USD Million) in 2024.
Switzerland Blood Plasma & Plasma Derived Medicinal Products Market is projected to grow at a CAGR of 6.61% during the forecast period of 2024 to 2032.
The estimated market value of the Switzerland Blood Plasma & Plasma Derived Medicinal Products Market for final year is USD 653.25 (USD Million).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.